Asia OneHealthcare files draft prospectus for Malaysia IPO

By Reuters News

By Yantoultra Ngui

- Malaysian hospital operator Asia OneHealthcare has filed a draft prospectus for an initial public offering of up to 4.38 billion shares and a planned listing on Bursa Malaysia, the Securities Commission Malaysia's website showed on Wednesday.

  • Reuters reported in April that US-based private equity firm TPG TPG.O had hired Maybank and UBS to explore options for Asia OneHealthcare, including a domestic listing that could value the company at about 30 billion ringgit ($7.4 billion)

  • The draft prospectus did not disclose the offer price, deal size or a listing date

  • The offering involves the sale of up to 3.86 billion existing shares by HLT Healthcare Holdings Singapore (HSG), through which TPG controls the hospital operator, and the issue of 521.1 million new shares by Asia OneHealthcare, the draft prospectus showed

  • The company plans to offer up to 3.77 billion shares to Malaysian and foreign institutional investors. It will offer 615.5 million shares to its managing director, employees, people who contributed to the group and the Malaysian public

  • HSG would retain a 73.9% stake after the IPO if an over-allotment option is not used. The option allows for the sale of up to 657.1 million additional existing shares, according to the draft prospectus

  • Asia OneHealthcare will use proceeds from the new shares to expand its hospitals, facility and equipment maintenance, partial debt repayment and IPO expenses, the draft prospectus said

  • The company operates 23 hospitals, including 22 in Malaysia and one in Vietnam, according to the draft prospectus

  • Asia OneHealthcare made a net profit of 344.4 million ringgit in the year ended March 2026, compared with 85.8 million ringgit net loss a year earlier. Revenue rose 13.6% on-year to 3.29 billion ringgit.

($1 = 4.0740 ringgit)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.